A detailed history of Oppenheimer Asset Management Inc. transactions in Globus Medical Inc stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 23,360 shares of GMED stock, worth $1.95 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
23,360
Previous 25,110 6.97%
Holding current value
$1.95 Million
Previous $1.72 Million 2.79%
% of portfolio
0.02%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$67.08 - $73.92 $117,390 - $129,360
-1,750 Reduced 6.97%
23,360 $1.67 Million
Q2 2024

Aug 08, 2024

BUY
$49.79 - $68.85 $152,307 - $210,612
3,059 Added 13.87%
25,110 $1.72 Million
Q1 2024

May 06, 2024

SELL
$51.15 - $56.52 $98,463 - $108,801
-1,925 Reduced 8.03%
22,051 $1.18 Million
Q4 2023

Feb 13, 2024

BUY
$43.79 - $55.14 $128,217 - $161,449
2,928 Added 13.91%
23,976 $1.28 Million
Q3 2023

Nov 07, 2023

BUY
$49.1 - $62.37 $108,805 - $138,211
2,216 Added 11.77%
21,048 $1.05 Million
Q2 2023

Aug 02, 2023

BUY
$52.61 - $59.54 $120,003 - $135,810
2,281 Added 13.78%
18,832 $1.12 Million
Q1 2023

May 10, 2023

SELL
$51.83 - $79.63 $14,719 - $22,614
-284 Reduced 1.69%
16,551 $937,000
Q4 2022

Feb 06, 2023

BUY
$58.4 - $75.53 $187,172 - $242,073
3,205 Added 23.51%
16,835 $1.25 Million
Q3 2022

Nov 14, 2022

SELL
$55.32 - $67.54 $885 - $1,080
-16 Reduced 0.12%
13,630 $812,000
Q2 2022

Aug 08, 2022

SELL
$53.08 - $81.37 $9,660 - $14,809
-182 Reduced 1.32%
13,646 $766,000
Q1 2022

May 12, 2022

SELL
$63.68 - $75.54 $2,228 - $2,643
-35 Reduced 0.25%
13,828 $1.02 Million
Q4 2021

Feb 02, 2022

SELL
$62.62 - $79.92 $26,363 - $33,646
-421 Reduced 2.95%
13,863 $1 Million
Q3 2021

Nov 12, 2021

BUY
$76.41 - $84.06 $13,142 - $14,458
172 Added 1.22%
14,284 $1.09 Million
Q2 2021

Aug 03, 2021

BUY
$61.85 - $77.53 $10,761 - $13,490
174 Added 1.25%
14,112 $1.09 Million
Q1 2021

May 17, 2021

BUY
$60.05 - $67.74 $17,474 - $19,712
291 Added 2.13%
13,938 $860,000
Q4 2020

Feb 11, 2021

BUY
$48.89 - $65.87 $27,280 - $36,755
558 Added 4.26%
13,647 $890,000
Q3 2020

Nov 13, 2020

BUY
$45.26 - $57.82 $592,408 - $756,805
13,089 New
13,089 $648,000
Q2 2020

Aug 11, 2020

SELL
$39.81 - $55.61 $87,980 - $122,898
-2,210 Closed
0 $0
Q1 2020

May 08, 2020

SELL
$35.06 - $59.45 $53,606 - $90,899
-1,529 Reduced 40.89%
2,210 $94,000
Q4 2019

Feb 07, 2020

BUY
$49.45 - $59.5 $1,285 - $1,547
26 Added 0.7%
3,739 $221,000
Q3 2019

Oct 31, 2019

SELL
$40.41 - $52.32 $10,506 - $13,603
-260 Reduced 6.54%
3,713 $190,000
Q2 2019

Aug 09, 2019

SELL
$39.3 - $48.41 $120,690 - $148,667
-3,071 Reduced 43.6%
3,973 $168,000
Q1 2019

Apr 24, 2019

SELL
$38.08 - $49.41 $51,979 - $67,444
-1,365 Reduced 16.23%
7,044 $347,000
Q4 2018

Jan 30, 2019

SELL
$41.38 - $57.44 $5,669 - $7,869
-137 Reduced 1.6%
8,409 $364,000
Q3 2018

Oct 26, 2018

SELL
$50.24 - $56.76 $4,069 - $4,597
-81 Reduced 0.94%
8,546 $485,000
Q2 2018

Aug 10, 2018

SELL
$47.96 - $57.41 $58,751 - $70,327
-1,225 Reduced 12.43%
8,627 $435,000
Q1 2018

May 09, 2018

BUY
$42.75 - $51.73 $30,438 - $36,831
712 Added 7.79%
9,852 $490,000
Q3 2017

Nov 14, 2017

BUY
$28.28 - $30.85 $258,479 - $281,969
9,140
9,140 $272,000

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $6.43B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track This Portfolio

Track Oppenheimer Asset Management Inc. Portfolio

Follow Oppenheimer Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.